CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Audiences
1.1 Research Methodology
1.1.1 Secondary Research
1.1.2 Primary Research
1.1.3 Analyst Tools and Models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 ASIA-PACIFIC IVF DEVICES MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Alternative Technologies
3.2.1 Intrauterine Insemination (IUI) Technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks
3.2.2 Difference between IUI and IVF Technique
3.2.3 GIFT Technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT Technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF Procedures by Fertility Drugs and Surgeries
3.3.1 Female Infertility Treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male Infertility Treatments
3.4 Costs Related to IVF Procedures
3.5 Role of Donors in the IVF Market
3.5.1 Egg Donation
3.5.1.1 Egg sharing
3.5.2 Sperm Donation
3.5.3 Embryo Donation
3.5.4 Donation for Research
3.6 Surrogacy
3.6.1 Legal Issues
3.7 Rise in Same Sex Couples
3.7.1 Artificial Insemination
3.7.2 Surrogate Mothers
3.7.3 In-Vitro Fertilization
3.8 Advanced Technologies in IVF
3.8.1 Capsule IVF
3.8.2 Three Parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility Treatment and Gender Selection
3.9.1 Methods of Sex Selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in Embryo Screening Methods
3.11 Application of Stem Cells in IVF
3.12 IVF and Resource Poor Countries
3.13 Key Findings
3.13.1 Top Factors Impacting for Asia-Pacific IVF Devices Market
3.13.2 Top Winning Strategies for Asia-Pacific IVF Devices Market
3.14 Porters Five Forces Analysis
3.14.1 Competition Declining Suppliers Power
3.14.2 Availability of Options Impacting Buyer Power
3.14.3 High Cost -A Hindrance to New Entrants
3.14.4 Application of Strategies to Overcome Competition
3.14.5 Less Threat from Substitutes
3.15 Value Chain Analysis
3.16 Patent Analysis
3.16.1 Patent Analysis by Type of Patents
3.16.2 Patents Analysis by Geography
3.17 Government Regulations
3.18 Clinical Trials
3.18.1 Trial 1: To Study the DHEA Outcomes on Poor Responders of IVF
3.18.2 Trial 2: Use of Metformin in IVF Treatment of Polycystic Ovary Syndrome
3.18.3 Trial 3- Treatment of First Line Unexplained Infertility by IVF and IUI in Controlled Ovarian Stimulation
3.18.4 Trial 4: Fast Track to IVF (FASTT) vs Conventional Infertility Treatment
3.18.5 Trial 5: To Study the Evaluation of Multiple Doses of NT100 in Women with Repeated IVF Failures
3.19 Market Dynamics
3.19.1 Drivers
3.19.1.1 Delayed pregnancies in women
3.19.1.2 Rise in global infertility rates
3.19.1.3 Advancement in technology
3.19.1.4 Rise in gamete donations
3.19.1.5 Rise in disposable income
3.19.1.6 Increase in success rates
3.19.2 Restraints
3.19.2.1 Cost constraints
3.19.2.2 Ethical and legal issues
3.19.2.3 Multiple pregnancies
3.19.2.4 Low awareness level
3.19.3 Opportunities
3.19.3.1 Fertility tourism
3.19.3.2 Growing number of fertility clinics
3.19.3.3 Rise in same sex marriages
CHAPTER 4 BY INSTRUMENTS
4.1 Incubators
4.1.1 Asia-Pacific IVF Incubators Market by Countries
4.2 Cryosystem
4.2.1 Asia-Pacific IVF Cryosystem Market by Countries
4.3 Imaging System
4.3.1 Asia-Pacific IVF Imaging System Market by Countries
4.4 Cabinet (Work Station)
4.4.1 Asia-Pacific IVF Cabinets Market by Countries
4.5 Ovum Aspiration Pump
4.5.1 Asia-Pacific IVF Ovum Aspiration Pump Market by Geography
4.6 Sperm Separation System
4.6.1 Asia-Pacific IVF Sperm Separation System Market by Countries
4.7 Accessories and Disposables
4.7.1 Semen Analysis Chamber
4.7.2 Plastic Ware
4.7.3 Oocyte Retrieval Needles
4.7.4 Miscellaneous Disposables
4.7.5 Asia-Pacific IVF Accessories and Disposable Market by Countries
4.8 Micro Manipulator System
4.8.1 Asia-Pacific IVF Micromanipulator Market by Countries
4.9 Others
4.9.1 Refrigerators
4.9.2 Asia-Pacific IVF Other Instruments Market by Countries
CHAPTER 5 BY REAGENTS AND MEDIA
5.1 Cryopreservation Media
5.1.1 Embryo Cryopreservation Media
5.1.2 Sperm Cryopreservation Media
5.1.3 Oocyte Cryopreservation Media
5.1.4 Asia-Pacific IVF Cryopreservation Media Market by Countries
5.2 Semen Processing Media
5.2.1 Asia-Pacific IVF Semen Processing Media Market by Countries
5.3 Ovum Processing Media
5.3.1 Asia-Pacific IVF Ovum Processing Media Market by Countries
5.4 Embryo Culture Media
5.4.1 Asia-Pacific IVF Embryo Culture Media Market by Geography
CHAPTER 6 BY TECHNIQUE
6.1 Fresh Embryo IVF
6.1.1 Drivers
6.1.2 Restraints
6.1.3 Asia-Pacific Fresh Embryo IVF Market, by Countries
6.2 Frozen Egg IVF
6.2.1 Reasons to Use this Technique
6.2.2 Advantages of Frozen Egg IVF Technique
6.2.3 Disadvantages of Frozen Egg IVF Technique
6.2.4 Asia-Pacific Frozen Egg IVF Market by Countries
6.3 Donor Egg IVF
6.3.1 Benefits of Donor Egg IVF Technique
6.3.2 Risks Associated with Donor Egg IVF Technique
6.3.3 Asia-Pacific Donor Egg IVF Market by Countries
CHAPTER 7 BY END USERS
7.1 Hospitals
7.1.1 Asia-Pacific IVF Hospitals Market by Countries
7.2 Surgical Centers
7.2.1 Asia-Pacific IVF Surgical Centres Market by Countries
7.3 Clinical Research Institutes
7.3.1 Asia-Pacific IVF Clinical Research Institutes Market by Countries
7.4 Clinics
7.4.1 Asia-Pacific IVF Clinics Market by Countries
CHAPTER 8 BY COUNTRIES
8.1.1 Asia Pacific IVF Devices Market
8.1.2 Asia-Pacific IVF Devices Market, by Country
8.1.2.1 India IVF devices and consumables market
8.1.2.2 China IVF devices and consumables market
8.1.2.3 Japan IVF devices and consumables market
8.1.2.4 Australia IVF devices and consumables market
8.1.2.5 Others IVF devices and consumables market
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company Overview
9.1.2 Company Snapshot
9.1.3 Business Performance
9.1.4 Strategic Moves and Developments
9.1.4.1 Primary strategies
9.1.4.2 Other strategies
9.1.5 SWOT Analysis of Vitrolife AB
9.2 Merck Serono, Inc.
9.2.1 Company Overview
9.2.2 Company Snapshot
9.2.3 Business Performance
9.2.4 Strategic Moves and Developments
9.2.4.1 Primary strategies
9.2.5 SWOT Analysis of Merck Serono, Inc.
9.3 Irvine Scientific
9.3.1 Company Overview
9.3.2 Company Snapshot
9.3.3 Business Performance
9.3.4 Strategic Moves and Developments
9.3.4.1 Primary strategy
9.3.5 SWOT Analysis of Irvine Scientific
9.4 Cooper Surgical, Inc.
9.4.1 Company Overview
9.4.2 Company Snapshot
9.4.3 Business Performance
9.4.4 Strategic Moves and Developments
9.4.4.1 Primary strategies
9.4.5 SWOT Analysis of Cooper Surgical, Inc.
9.5 Cook Medical, Inc.
9.5.1 Company Overview
9.5.2 Company Snapshot
9.5.3 Strategic Moves and Developments
9.5.3.1 Primary strategies
9.5.4 SWOT Analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company Overview:
9.6.2 Company Snapshot
9.6.3 Business Performance
9.6.4 Strategic Moves and Developments
9.6.4.1 Primary strategies
9.6.5 SWOT Analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
9.7.1 Company Overview
9.7.2 Company Snapshot
9.7.3 Strategic Moves and Developments
9.7.3.1 Primary strategy
9.7.4 SWOT Analysis of Genea Biomedx
9.8 KetaZato Corporation
9.8.1 Company Overview
9.8.2 Company Snapshot
9.8.3 Strategic Moves and Developments
9.8.3.1 Primary strategies
9.8.4 SWOT Analysis of KetaZato Corporation
9.9 OvaScience, Inc.
9.9.1 Company Overview
9.9.2 Company Snapshot
9.9.3 Business Performance
9.9.4 Strategic Moves a nd Developments
9.9.4.1 Primary strategy
9.9.5 SWOT analysis of OvaScience, Inc.